Literature DB >> 1667382

Developmental expression of two murine fibroblast growth factor receptors, flg and bek.

A Orr-Urtreger1, D Givol, A Yayon, Y Yarden, P Lonai.   

Abstract

Developmental expression of two closely related fibroblast growth factor receptors, bek and flg, is described from early postimplantation until advanced organogenesis. Transcripts of bek and flg were first seen in the primitive ectoderm of egg-cylinder-stage embryos. Later, starting with somitogenesis, and then throughout embryogenesis, they were actively transcribed both in the mesoderm and neuroectoderm. Bek was expressed also in the surface ectoderm and in various epithelia, whereas flg expression was restricted mainly to the mesenchyme. In the limb bud bek transcripts displayed a gradient-like distribution and appeared earlier than flg. The two receptors, in contrast to their almost identical ligand binding specificity, displayed distinct spatial specificities throughout development, suggesting that developmental localization may contribute to functional specificity. The role of bek and flg in gastrulation and in epithelial-mesenchymal interactions of organogenesis will be discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1667382     DOI: 10.1242/dev.113.4.1419

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  78 in total

1.  Fgfr2 is required for limb outgrowth and lung-branching morphogenesis.

Authors:  E Arman; R Haffner-Krausz; M Gorivodsky; P Lonai
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Uncoupling fibroblast growth factor receptor 2 ligand binding specificity leads to Apert syndrome-like phenotypes.

Authors:  K Yu; D M Ornitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 3.  Epithelial mesenchymal interactions, the ECM and limb development.

Authors:  Peter Lonai
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

4.  Fibroblast growth factor-2 stimulates the proliferation of mesenchyme-derived progenitor cells from aging mouse and human bone.

Authors:  Guomin Ou; Lyndon Charles; Seth Matton; Craig Rodner; Marja Hurley; Liisa Kuhn; Gloria Gronowicz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-07-19       Impact factor: 6.053

5.  Fibroblast growth factor signaling deficiencies impact female reproduction and kisspeptin neurons in mice.

Authors:  Brooke K Tata; Wilson C J Chung; Leah R Brooks; Scott I Kavanaugh; Pei-San Tsai
Journal:  Biol Reprod       Date:  2012-04-19       Impact factor: 4.285

6.  Apert syndrome without craniosynostosis.

Authors:  Diego de Ângelis Ramos; Hamilton Matushita; Daniel Dante Cardeal; Clarissa Nóbrega Gambarra Nascimento; Manoel Jacobsen Teixeira
Journal:  Childs Nerv Syst       Date:  2019-01-14       Impact factor: 1.475

7.  Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy.

Authors:  G Yan; Y Fukabori; G McBride; S Nikolaropolous; W L McKeehan
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

8.  Canonical transient receptor potential 1 plays a role in basic fibroblast growth factor (bFGF)/FGF receptor-1-induced Ca2+ entry and embryonic rat neural stem cell proliferation.

Authors:  Alessandra Fiorio Pla; Dragan Maric; So-Ching Brazer; Paolo Giacobini; Xibao Liu; Yoong Hee Chang; Indu S Ambudkar; Jeffery L Barker
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

9.  Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull.

Authors:  Y H Liu; R Kundu; L Wu; W Luo; M A Ignelzi; M L Snead; R E Maxson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

Review 10.  The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain.

Authors:  G Mudò; A Bonomo; V Di Liberto; M Frinchi; K Fuxe; Natale Belluardo
Journal:  J Neural Transm (Vienna)       Date:  2009-03-17       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.